Licensee’s Group Sample Clauses

Licensee’s Group. 1.1 Börse Berlin AG allows Licensee’s Group to include Affiliated Companies and Service Facilitators. Service Facilitators are subject to prior written approval by Börse Berlin AG and must be listed on the Order Form. 1.2 An Affiliated Company or a Service Facilitator accepted by Börse Berlin AG in accordance with this Agreement is licensed by this Agreement to use Equiduct Products or Information only within the Service. Licensee remains liable for Fees applicable to use of Equiduct Products or Information within the Service by Affiliated Companies or Service Facilitators. 1.3 Service Facilitators may include agents of Licensee, owners or operators of websites displaying the Service, software developers, facilities managers, introducing brokers, property managers or providers of other support services. 1.4 Unless otherwise specified by Börse Berlin AG, approval of Service Facilitators will be subject to the following conditions: (a) Licensee retains full control, either technically or via an agreement acceptable to Börse Berlin AG, over all use or display of Equiduct Products or Information within the Service as provided via Service Facilitator, (b) Licensee is party to any agreement with Customers governing access to and use of the Service provided via the Service Facilitator, (c) Licensee unconditionally guarantees and accepts responsibility for performance of all obligations under the Agreement in respect of Equiduct Products or Information distributed via the Service Facilitator.
Licensee’s Group. If you would like an Affiliated Company or Service Facilitator to have access to Information, please complete Table 9. You may regard changes to Table 9.1 as accepted by BHB unless BHB notifies you of an objection within thirty (30) days of your notification of the changes. All proposed changes to Table 9.2 are subject to prior written approval of BHB.
Licensee’s Group. 1.1. BHB allows Licensee’s Group to include Affiliated Companies and Service Facilitators. Service Facilitators are subject to prior written approval by BHB. 1.2. An Affiliated Company or a Service Facilitator accepted by BHB in accordance with the XXX Application Form and XXX Summary Clause 17.2 is licensed by this Agreement to use Information only within the Service. Licensee remains liable for Fees and Charges applicable to use of Information within the Service by Affiliated Companies or Service Facilitators. BHB reserves rights to provide or withhold permission for any Person to act as a Service Facilitator and to apply such additional terms in respect of any Service Facilitator as BHB deems appropriate. 1.3. Service Facilitators may include applications service providers, telecom companies, agents of Licensee, owners or operators of Websites displaying the Service, software developers, facilities managers, introducing brokers, property managers or providers of other support services. 1.4. Unless otherwise specified by BHB, approval of Service Facilitators will be subject to the following conditions: a) Licensee retains full control, either technically or via an agreement acceptable to BHB, over all display of Information within the Service as provided via Service Facilitator. b) Licensee retains full control, either technically or via an agreement acceptable to BHB, over the release to Subscribers of Information and the maintenance of Operational Controls over all User access to Information where required by this Agreement, within any Service provided via the proposed Service Facilitator. c) Licensee is party to any agreement with Subscribers governing access to and use of the Service provided via the proposed Service Facilitator. d) All Services provided via the proposed Service Facilitator are clearly identified, branded or co-branded as Services of Licensee or an Affiliated Company of Licensee covered by this Agreement. e) Licensee unconditionally guarantees and accepts responsibility for performance of all obligations under the Agreement in respect of Information distributed via Service Facilitator. 1.5. BHB reserves the right to inspect and audit agreements and controls relating to the use of Information by a proposed Service Facilitator. 1.6. Service Facilitators have no rights under this Agreement to use Information outside the Service. 1.7. BHB reserves all rights to withdraw approval of any Service Facilitator and/or require any Service Facil...
Licensee’s Group. Without prejudice to the Licensee's obligations under these Conditions in respect, in particular, of anything done on its behalf, where:
Licensee’s Group the Licensee and companies directly or indirectly Controlled by the Licensee or a Controlling company of the Licensee and companies under its Control, listed in Appendix 2 to this Agreement. The list of companies of the Licensee’s Group may be amended by the Licensee in accordance with Appendix 2 to this Agreement; Index - any numerical representation of the value, volatility or other characteristic of a financial market, market sector or group of assets, calculated and recalculated from time to time on a standard basis in order to reflect movements in the underlying component data; Other Non-display Use Applications – Applications or systems that use Information for the purposes of risk management, quantitative analysis, fund administration, portfolio management or the generation of trading signals to support manual trading activities, but do not involve or result in the display or dissemination of the Information; Unit of Count - a method of identifying, registering and controlling access to the Information, as specified in Appendix 5 to the Agreement. Control – holding more than 50% of the share capital of the controlled entity or such other percentage of the share capital as required to determine and change the composition of the management board and the business activity of the controlled entity. Operational Controls - the systems, rules, procedures, authorisations and policies which, taken together and to the satisfaction of the Stock Exchange:

Related to Licensee’s Group

  • Sublicensees Licensee shall have the full right (but not the obligation) to sublicense those rights granted to it under Section 2.1 to a Third Party (a “Sublicensee”); provided, however, that, prior to the payment of the first milestone pursuant to Section 7.2, Licensee may not grant any such sublicense to any contract research organization conducting Clinical Trials of Products or any Third Parties conducting contract Manufacturing activities without Licensee’s prior written notice (at least twenty (20) Business Days in advance) to Lilly, which shall include a description of the rights to be granted and the purpose therefor, the identity of the Third Party and the countries involved, and Lilly’s prior written consent, but such consent shall only be required (i) until such time as Licensee is the holder of record for the Regulatory Materials related to Taladegib and (ii) to the extent such organization is not performing services for Licensee as of the Effective Date; and provided further, that Licensee shall remain responsible for the performance by any of its Sublicensees. With respect to any Sublicensee granted a sublicense to any Commercialization rights hereunder, Licensee shall ensure that each of its Sublicensees accepts in writing all applicable terms and conditions of this Agreement, including the non-compete, reporting, audit, inspection and confidentiality provisions hereunder. Each Sublicensee shall also be prohibited from further sublicensing. For the avoidance of doubt, (a) Licensee will remain directly responsible for all amounts owed to Lilly under this Agreement, and (b) each Sublicensee is subject to the negative and restrictive covenants set forth in Sections 2.3.1 and 2.5, respectively. Licensee hereby expressly waives any requirement that Lilly exhaust any right, power or remedy, or proceed against a subcontractor, for any obligation or performance hereunder prior to proceeding directly against Licensee.

  • Licensee “Licensee” means the individual or company that has entered into an Agreement with the Embassy. “Offer” means a response to a solicitation that, if accepted, would bind the offeror to perform the resultant Agreement.

  • University Any notice may be served upon the University by delivering it, in writing, to the University at the address set forth on the last page of this Agreement, by depositing it in a United States Postal Service deposit box with the postage fully prepaid and with the notice addressed to the University at the aforementioned address, or by sending a facsimile of it to the University facsimile number set forth on the last page of this Agreement.

  • Licensor any Person from whom a Grantor obtains the right to use any Intellectual Property. Lien: any Person’s interest in Property securing an obligation owed to, or a claim by, such Person, whether such interest is based on common law, statute or contract, including liens, security interests, pledges, hypothecations, statutory trusts, reservations, exceptions, encroachments, easements, rights-of-way, covenants, conditions, restrictions, leases, and other title exceptions and encumbrances affecting Property. Lien Waiver: an agreement, in form and substance satisfactory to Collateral Agent, by which (a) for any material Collateral located on leased premises, the lessor waives or subordinates any Lien it may have on the Collateral, and agrees to permit Collateral Agent to enter upon the premises and remove the Collateral or to use the premises to store or dispose of the Collateral; (b) for any Collateral held by a warehouseman, processor, shipper, customs broker or freight forwarder, such Person waives or subordinates any Lien it may have on the Collateral, agrees to hold any Documents in its possession relating to the Collateral as agent for Collateral Agent, and agrees to deliver the Collateral to Collateral Agent upon request; (c) for any Collateral held by a repairman, mechanic or bailee, such Person acknowledges Collateral Agent’s Lien, waives or subordinates any Lien it may have on the Collateral, and agrees to deliver the Collateral to Collateral Agent upon request; and (d) for any Collateral subject to a Licensor’s Intellectual Property rights, the Licensor grants to Collateral Agent the right, vis-à-vis such Licensor, to enforce Collateral Agent’s Liens with respect to the Collateral, including the right to dispose of it with the benefit of the Intellectual Property, whether or not a default exists under any applicable License.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Territory 33.1 This Agreement applies to the territory in which CenturyLink operates as an ILEC in the State. CenturyLink shall be obligated to provide services under this Agreement only within this territory. 33.2 Notwithstanding any other provision of this Agreement, CenturyLink may terminate this Agreement as to a specific operating territory or portion thereof pursuant to Section 6.7 of this Agreement.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Distributors In addition to direct sales to Clients, Supplier grants Accenture: (i) the right to resell Products and Services to a third-party

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!